学术探索
学术期刊
新闻热点
数据分析
智能评审

Biosynthesis of dobutamine monoglucuronides and glucuronidation of dobutamine by recombinant human UDP-glucuronosyltransferases

被引：21
作者：
Alonen, A
Aitio, O
Hakala, K
Luukkanen, L
Finel, M
Kostiainen, R
机构：
[1] Univ Helsinki, Fac Pharm, Div Pharmaceut Chem, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Fac Pharm, Viikki Drug Discovery Technol Ctr, FIN-00014 Helsinki, Finland
来源：
DRUG METABOLISM AND DISPOSITION | 2005年 / 33卷 / 05期
关键词：
D O I：
10.1124/dmd.104.002139
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Selected aspects of dobutamine glucuronidation were studied in detail. There are potentially four sites at which dobutamine can be conjugated to glucuronic acid. Three of the four dobutamine monoglucuronides that can be formed were enzymatically synthesized using pig liver microsomes, isolated, and characterized by tandem mass spectrometry, and H-1 and C-13 NMR spectroscopy. Analysis of dobutamine glucuronidation by liver microsomes from various sources revealed large variability in the ratios of the three regioisomers. Interestingly, catecholic dobutamine meta-O-glucuronide, by far the major product synthesized with human liver microsomes, was only a minor product for rat liver microsomes. Rabbit liver microsomes yielded diglucuronides, in addition to monoglucuronides. Activities of individual recombinant human UDP-glucuronosyltransferases (UGTs) were investigated, and the results suggested that dobutamine glucuronidation in the human liver is mainly carried out by UGTs 2B7 and 1A9. Among the extrahepatic UGTs, the formation of monoglucuronides, mainly catecholic meta-O-glucuronide, by UGTs 1A7 and 1A8 was similar to that by 1A9, whereas UGT1A10 also efficiently catalyzed the formation of catecholic dobutamine para-O-glucuronide.
引用
收藏
页码：657 / 663
页数：7
相关论文
共 20 条
[1]   SPECIFICITY OF HUMAN UDP-GLUCURONOSYLTRANSFERASES AND XENOBIOTIC GLUCURONIDATION [J].
BURCHELL, B ;
BRIERLEY, CH ;
RANCE, D .
LIFE SCIENCES, 1995, 57 (20) :1819-1831
[2]  
Chiu SHL, 1998, DRUG METAB DISPOS, V26, P838
[3]  
HUSKEY SEW, 1993, DRUG METAB DISPOS, V21, P792
[4]   Simultaneous expression of guinea pig UDP-glucuronosyltransferase 2B21 (UGT2B21) and 2B22 in COS-7 cells enhances UGT2B21-catalyzed chloramphenicol glucuronidation [J].
Ishii, Y ;
Miyoshi, A ;
Maji, D ;
Yamada, H ;
Oguri, K .
DRUG METABOLISM AND DISPOSITION, 2004, 32 (10) :1057-1060
[5]   N-glucuronidation of some 4-arylalkyl-1H-imidazoles by rat, dog, and human liver microsomes [J].
Kaivosaari, S ;
Salonen, JS ;
Taskinen, J .
DRUG METABOLISM AND DISPOSITION, 2002, 30 (03) :295-300
[6]   Regioselective glucuronidation of denopamine: Marked species differences and identification of human UDP-glucuronosyltransferase isoform [J].
Kaji, H ;
Kume, T .
DRUG METABOLISM AND DISPOSITION, 2005, 33 (03) :403-412
[7]   Comparison of electrospray, atmospheric pressure chemical ionization, and atmospheric pressure photoionization in the identification of apomorphine, dobutamine, and entacapone phase II metabolites in biological samples [J].
Keski-Hynnilä, H ;
Kurkela, M ;
Elovaara, E ;
Antonio, L ;
Magdalou, J ;
Luukkanen, L ;
Taskinen, J ;
Kostiainen, R .
ANALYTICAL CHEMISTRY, 2002, 74 (14) :3449-3457
[8]   The interactions between the N-terminal and C-terminal domains of the human UDP-glucuronosyltransferases are partly isoform-specific, and may involve both monomers [J].
Kurkela, M ;
Hirvonen, J ;
Kostiainen, R ;
Finel, M .
BIOCHEMICAL PHARMACOLOGY, 2004, 68 (12) :2443-2450
[9]   Expression and characterization of recombinant human UDP-glucuronosyltransferases (UGTs) [J].
Kurkela, M ;
García-Horsman, JA ;
Luukkanen, L ;
Mörsky, S ;
Taskinen, J ;
Baumann, M ;
Kostiainen, R ;
Hirvonen, J ;
Finel, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (06) :3536-3544
[10]   Glucuronidation of anabolic androgenic steroids by recombinant human UDP-glucuronosyltransferases [J].
Kuuranne, T ;
Kurkela, M ;
Thevis, M ;
Schänzer, W ;
Finel, M ;
Kostiainen, R .
DRUG METABOLISM AND DISPOSITION, 2003, 31 (09) :1117-1124
12